Autopsy report · NCT00621283

Secretin Enhanced MRCP for Evaluation of Pancreatic Duct in Pediatric Population

“Poor patient enrollment due to logistical issues”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 10 months before it stopped.
• 0 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Massachusetts General Hospital

Sponsor type

University, hospital or other

Conditions

Acute Recurrent Pancreatitis; Chronic Pancreatitis

Interventions

RG1068 (Synthetic Human Secretin)

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Assisted Animal Therapy: ReAnimal
  “Patient enrollment and logistical problems” (93% match in meaning)
• Intravitreal Dexamethasone Implant (Ozurdex) Versus Bevacizumab in Patients With Diabetic Macular Edema Undergoing Cataract Surgery
  “Inadequate patient enrollment” (83% match in meaning)
• Outpatient Treatment of Gram Positive Wound Infections in the Diabetic Foot: A Pharmaco-economic Comparison of Daptomycin vs. Vancomycin Based Regimens
  “Lack of patient enrollment” (83% match in meaning)
• Pericapsular Exparel for Pain Relief in Bunionectomy and Related Procedures
  “Logistical issues prevent efficient enrollment” (78% match in meaning)
• The Effect of Thalidomide in Suppression of the Systemic Inflammatory Response Syndrome in Hemodialysis Patients
  “Low enrollment -- We could not recruit patients willing to be enrolled” (76% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.